Business
Allegro and American Regent sign exclusive licensing deal for SynoglideTM, a novel osteoarthritis treatment in animal health, valued at up to $35 million
Global license provides American Regent, a wholly owned subsidiary of Daiichi Sankyo, with rights to commercialize Synoglide™ in the veterinary market in most countries of the world. Allegro retains rights to human applications for its technology, enabling the company to focus on human clinical development of its osteoarthritis candidateUnder the terms of the agreement, Allegro has received an upfront payment and is eligible to receive commercialization and sales milestone payments up to $35 mil
About this update from Daiichi Sankyo Company, Limited
[{"type":"image","alt":"Allegro NV; American Regent","displaySize":"","headline":null,"caption":"Allegro NV; American Regent","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":189,"url":"https://media.zenfs.com/en/globenewswire.com/a3f31daf7365154f01d64134e7cfef81"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mH2VIm_lpJ1swEdrEe1sEg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTI2NTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/a3f31daf7365154f01d64134e7cfef81","width":300,"height":189}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":290,"height":118,"url":"https://media.zenfs.com/en/globenewswire.com/673f6787f16f6575cea6f2363d9e333a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9RSieZuob0ndhyTobxx1Yw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/673f6787f16f6575cea6f2363d9e333a","width":290,"height":118}}},{"type":"text","content":" ","length":337,"tagName":"p"},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","className":"","disableSlideshowImg":false,"size":{"original":{"width":974,"height":165,"url":"https://media.zenfs.com/en/globenewswire.com/69db8604bce7433352be145d8a7e6f18"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Oa76ZERYVW_kqWAnNrAAbA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTE2MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/69db8604bce7433352be145d8a7e6f18","width":960,"height":163},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/fpxwN1I31NzcwcVeWJsnGw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE5NDg7aD0zMzA7Y2Y9d2VicA--/https://media.zenfs.com/en/globenewswire.com/69db8604bce7433352be145d8a7e6f18","width":974,"height":165}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Global license provides American Regent, a wholly owned subsidiary of Daiichi Sankyo, with rights to commercialize Synoglide™ in the veterinary market ...